Prognostic value of preoperative CT features for disease-free survival in patients with primary gastric gastrointestinal stromal tumors after resection

[1] Hirota S(1998)Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors Science 279 577-580

[2] Isozaki K(2012)Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts Lancet Oncol 13 265-274

[3] Moriyama Y(2000)Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival Ann Surg 231 51-58

[4] Hashimoto K(2020)Development and validation of a prognostic nomogram to predict recurrence in high-risk gastrointestinal stromal tumour: A retrospective analysis of two independent cohorts EBioMedicine 60 620-625

[5] Nishida T(2008)Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT J Clin Oncol 26 973-983

[6] Ishiguro S(2013)Gastrointestinal stromal tumour Lancet 382 1411-1419

[7] Joensuu H(2008)Risk stratification of patients diagnosed with gastrointestinal stromal tumor Hum Pathol 39 70-83

[8] Vehtari A(2006)Gastrointestinal stromal tumors: Pathology and prognosis at different sites Seminars in Diagnostic Pathology 23 2796-2803

[9] Riihimäki J(2017)China Gastrointestinal Stromal Tumor Study, Group. Prognostic role of tumor necrosis in patients undergoing curative resection for gastric gastrointestinal stromal tumor: a multicenter analysis of 740 cases in China Cancer Med 6 432-438

[10] Nishida T(2021)Tumor necrosis is significantly associated with reduced recurrence-free survival after curative resection of gastrointestinal stromal tumors J Surg Oncol 123 1559-1568

[1] Hirota S(1998)Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors Science 279 577-580

[2] Isozaki K(2012)Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts Lancet Oncol 13 265-274

[3] Moriyama Y(2000)Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival Ann Surg 231 51-58

[4] Hashimoto K(2020)Development and validation of a prognostic nomogram to predict recurrence in high-risk gastrointestinal stromal tumour: A retrospective analysis of two independent cohorts EBioMedicine 60 620-625

[5] Nishida T(2008)Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT J Clin Oncol 26 973-983

[6] Ishiguro S(2013)Gastrointestinal stromal tumour Lancet 382 1411-1419

[7] Joensuu H(2008)Risk stratification of patients diagnosed with gastrointestinal stromal tumor Hum Pathol 39 70-83

[8] Vehtari A(2006)Gastrointestinal stromal tumors: Pathology and prognosis at different sites Seminars in Diagnostic Pathology 23 2796-2803

[9] Riihimäki J(2017)China Gastrointestinal Stromal Tumor Study, Group. Prognostic role of tumor necrosis in patients undergoing curative resection for gastric gastrointestinal stromal tumor: a multicenter analysis of 740 cases in China Cancer Med 6 432-438

[10] Nishida T(2021)Tumor necrosis is significantly associated with reduced recurrence-free survival after curative resection of gastrointestinal stromal tumors J Surg Oncol 123 1559-1568